Effect of Phoxilium on prognostic predictors in patients undergoing continuous venovenous hemodiafiltration.

Kim, Da Woon; Kim, Hyo Jin; Kim, Jin Mi; Jeon, You Hyun; Han, Miyeun; Seong, Eun Young; Song, Sang Heon

Kim, Da Woon; Kim, Hyo Jin; Kim, Jin Mi; Jeon, You Hyun; Han, Miyeun; Seong, Eun Young; Song, Sang Heon.

Afiliação

Kim DW; Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea.
Kim HJ; Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea.
Kim JM; Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Jeon YH; Department of Biostatistics, Clinical Trial Center, Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Han M; Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea.
Seong EY; Department of Internal Medicine, Hallym University Hangang Sacred Heart Hospital, Seoul, Republic of Korea.
Song SH; Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea.

Kidney Res Clin Pract ; 40(3): 457-471, 2021 Sep.

Article em En | MEDLINE | ID: mdl-34370933

Palavras-chave

Continuous renal replacement therapy; Continuous venovenous hemodiafiltration; Phosphorus; Phoxilium; Red cell distribution width

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google